Navigation Links
Underweight COPD patients at higher risk of death
Date:9/26/2011

Amsterdam, The Netherlands: Patients suffering from chronic obstructive pulmonary disease (COPD) are at a higher risk of death if they are underweight.

A new study, which will be presented today (26 September 2011) at the European Respiratory Society's Annual Congress in Amsterdam, assessed the link between death rates and the weight of COPD patients. The research also assessed the link with other co-existing diseases, such as heart disease.

The World Health Organization predicts that COPD will become the third leading cause of death worldwide by 2030. A number of co-morbid conditions often exist with COPD, including cardiovascular disease, muscle wasting, type-2 diabetes and asthma.

In a study by researchers at Uppsala University in Sweden, 552 patients were assessed. Information was collected using questionnaires to review patients' age, education, smoking status and level of care. They also looked at information on lung function and history of comorbidities.

The results showed that heart disease, hypertension and being underweight were all associated with higher mortality in COPD patients. People who were underweight were 1.7-times more likely to die than people with a normal body weight. Additionally, people with heart disease or cardiac failure were 1.9-times more likely to die than people with COPD alone.

The results were found even when taking into account age, sex, lung function and smoking.

The findings have important implications for health practitioners in both primary and secondary care settings.

Dr Bjorn Stallberg, from Uppsala University in Sweden, said: "As the population is aging, people are more likely to suffer from more than one condition at the any given time. It will be important for clinicians to recognise other symptoms outside of their specialist area to ensure patients are receiving all the necessary treatment. The findings of this study have shown that heart disease and being underweight are very serious conditions and therefore should be taken into consideration when managing patients with COPD."


'/>"/>

Contact: Lauren Anderson
lauren.anderson@europeanlung.org
31-610-860-810
European Lung Foundation
Source:Eurekalert

Related medicine news :

1. New evidence highlights risk of comorbidities for COPD patients
2. New hope for advanced post-menopausal breast cancer patients resistant to hormonal therapy
3. Abiraterone acetate improves fatigue in prostate cancer patients, says international clinical trial
4. Foam injections for varicose veins better for patients and cheaper, study finds
5. New bone-targeting drug delays onset of metastases in hormone-resistant prostate cancer patients
6. Infusing chemotherapy into the liver gives extra months of disease-free life in melanoma patients
7. Most Patients Want Experienced Surgeons, Not Trainees
8. Heart drug offers possible treatment for patients facing respiratory failure
9. Elderly breast cancer patients risk treatment discrimination
10. Lung Disease Puts Many Black Patients Back in Hospital: Report
11. Continued treatment for lupus may boost survival of those patients with end-stage kidney disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... , ... Current Meditation , a new meditation concept ... U.S. starting this spring. Current Meditation focuses on “meditation for the modern world,” ... will be the first meditation concept in the U.S. offering franchising opportunities, setting ...
(Date:2/23/2017)... ... (PRWEB) ... opportunity for the nation to come together to combine its ... – with its favorite fruit – apples! To celebrate National ... to join the “Apple Madness” bracket tournament – a five-week, ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that the Blüm ... in children aged 3-8 with Autism, is now enrolling at three new sites. These ... the United States. , “There are currently no approved drugs that address the ...
(Date:2/23/2017)... ... February 23, 2017 , ... Carlos Gutierrez has lived ... continued to spiritually evolve, which is the purpose of everyone in this universe. As ... ” (published by Balboa Press) attempts to guide readers to expand one’s spiritual life. ...
(Date:2/22/2017)... ... February 22, 2017 , ... Gevir, a New Zealand-based company that ... its products are coming soon to Amazon.com, the world’s largest online retailer. ... means to develop an effective natural treatment for Shelley’s Multiple Sclerosis, which she’d been ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017 Visiomed, the French ... since 1997, is changing the landscape of healthcare ... patients with pro-active, custom-made solutions. Recognizing the rising ... and affordable healthcare without walls, Visiomed has launched ... developed with healthcare professionals that is empowering the ...
(Date:2/23/2017)... SEOUL , Südkorea, 23. Februar 2017 ... LED für Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache ... kurzwellige ultraviolette Strahlung im Bereich zwischen 200 und 280 nm ... Ausbreitung von Bakterien, indem es ihre DNA zerstört. Das ... 280 nm. ...
(Date:2/23/2017)... REDWOOD CITY, Calif., Feb. 23, 2017 Nevro Corp. ... innovative evidence-based solutions for the treatment of chronic pain, today ... ended December 31, 2016. 2016 Accomplishment & ... the full year 2016, an increase of 228% as reported, ... million for 2016, an increase of 612% over the prior ...
Breaking Medicine Technology: